Recent landmark studies in melanoma, cutaneous squamous cell carcinoma (cSCC), head and neck cancer (HNC) and sarcoma have established neoadjuvant immune therapy as a potential standard of care for patients with locally advanced cancers.

Locally recurrent HNSCC in the setting of prior radiation therapy is a challenging clinical scenario.

Topics Included:

The ASTRO Coding and Coverage Seminar is designed to provide information to ASTRO members (radiation oncologists, radiation physicists, dosimetrists, radiation therapists), coding professionals and practice administrators on the topic of CPT codes and coverage within radiation oncology.